Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Region 2024-2032

Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A524
Buy Now

Market Overview:

The global pharmaceutical contract packaging market size reached US$ 21.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The increasing outsourcing trends, rising demand for medications and medical devices, stringent regulatory compliance, product diversification and cost-effectiveness, significant technological advancements, and increasing environmental considerations are some of the major factors propelling the market.

Report Attribute
 Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023 US$ 21.7 Billion
Market Forecast in 2032 US$ 39.9 Billion
Market Growth Rate (2024-2032) 6.8%


Pharmaceutical contract packaging refers to the outsourcing of packaging services by pharmaceutical companies to specialized contract packaging firms. These firms are equipped with the necessary infrastructure and expertise to handle the packaging of pharmaceutical products, including medications, medical devices, and related healthcare items. The process of pharmaceutical contract packaging involves various stages, including design, labeling, and assembly of the final product packaging. The contract packaging companies ensure compliance with regulatory guidelines and industry standards, such as Good Manufacturing Practices (GMP) and Quality Assurance (QA) protocols. By opting for contract packaging services, pharmaceutical companies can benefit from several advantages. It allows them to focus on their core competencies, such as research and development, while entrusting packaging responsibilities to experts. This leads to increased operational efficiency and reduced time-to-market for their products. Additionally, contract packaging firms can offer cost-effective solutions by leveraging economies of scale and optimizing packaging processes.

Pharmaceutical companies are increasingly outsourcing their non-core activities, including packaging, to contract packaging firms. This allows them to focus on core competencies like research and development, while benefiting from the expertise and efficiency of contract packaging specialists. Additionally, the pharmaceutical industry is subject to strict regulations and quality standards imposed by health authorities worldwide. Contract packaging companies are well-versed in these regulations, ensuring that pharmaceutical products are packaged and labeled in compliance with Good Manufacturing Practices (GMP) and other relevant guidelines. Other than this, the pharmaceutical market is continuously expanding with new drug developments, personalized medicines, and innovative medical devices. Contract packaging firms offer customized and flexible solutions to accommodate the diverse packaging requirements of these products. Besides this, contract packaging offers cost advantages to pharmaceutical companies by eliminating the need for heavy investments in packaging infrastructure and equipment. Instead, they can leverage the capabilities of established contract packaging providers, resulting in cost savings. In line with this, the global pharmaceutical industry is witnessing significant growth, especially in emerging markets. As pharmaceutical companies expand their reach to new regions, they seek reliable contract packaging partners to ensure efficient and compliant packaging in diverse markets. Furthermore, contract packaging companies are continually adopting advanced technologies and automation in their processes. These innovations improve packaging efficiency, reduce errors, and enhance overall productivity, making them attractive partners for pharmaceutical firms. Moreover, increasing awareness about sustainability and environmental impact has led to a growing demand for eco-friendly and recyclable packaging solutions. Contract packaging companies are aligning their offerings with these green initiatives to meet market demands.

Pharmaceutical Contract Packaging Market Trends/Drivers:

Increasing Outsourcing Trend

Pharmaceutical companies are increasingly turning to contract packaging firms to handle their packaging needs. This shift is primarily driven by the desire to focus on core competencies, such as drug development and marketing, while entrusting the specialized task of packaging to experienced professionals. By outsourcing packaging, pharmaceutical companies can streamline their operations, reduce operational costs, and improve overall efficiency. Contract packaging firms offer expertise in packaging materials, design, and regulatory compliance, which allows pharmaceutical companies to deliver high-quality products to the market in a timely manner. Additionally, outsourcing provides the flexibility to adapt to fluctuations in product demand, allowing pharmaceutical companies to respond swiftly to changing market dynamics.

Stringent Regulatory Compliance

The pharmaceutical industry is heavily regulated by various health authorities worldwide to ensure patient safety and product efficacy. Compliance with Good Manufacturing Practices (GMP) and other regulatory guidelines is paramount for pharmaceutical companies. Contract packaging firms specialize in adhering to these strict regulations, as they possess in-depth knowledge of the applicable quality standards and industry best practices. Their expertise ensures that pharmaceutical products are accurately labeled, packaged, and traceable throughout the supply chain, reducing the risk of non-compliance and potential legal issues. By partnering with contract packaging providers, pharmaceutical companies can maintain their reputation for producing safe and reliable products, while mitigating the risks associated with regulatory non-compliance.

Rising Demand for Medications and Medical Devices

The global pharmaceutical market is continuously expanding, with increasing demand for medications and medical devices across diverse regions. As pharmaceutical companies seek to penetrate new markets, they encounter unique packaging requirements and regional regulations. Contract packaging firms offer localized expertise and capabilities, enabling pharmaceutical companies to navigate the complexities of different markets seamlessly. These firms can adapt packaging designs, labeling, and language translations to comply with local regulations and cultural preferences. By partnering with contract packaging providers, pharmaceutical companies can efficiently enter new markets, capitalize on growth opportunities, and reach a broader customer base. This market expansion strategy allows pharmaceutical companies to extend their market presence while minimizing logistical challenges and ensuring a consistent and compliant packaging approach.

Pharmaceutical Contract Packaging Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical contract packaging market report, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on industry, type and packaging.

Breakup by Industry:

  • Small Molecule
  • Biopharmaceutical
  • Vaccine
     

The report has provided a detailed breakup and analysis of the market based on the industry. This includes small molecule, biopharmaceutical, and vaccine.

The small molecule pharmaceutical industry encompasses a broad range of traditional drugs that consist of low molecular weight compounds. These drugs are typically synthesized through chemical processes, and they constitute a significant portion of the pharmaceutical market. Small molecule drugs are widely used to treat various medical conditions and diseases, including cardiovascular disorders, infectious diseases, and metabolic disorders. Due to their relatively simple structure, small molecules can be easily mass-produced and formulated into different dosage forms, such as tablets and capsules. They also have a well-established manufacturing and packaging process, making them cost-effective to produce and distribute. The small molecule pharmaceutical industry remains a vital segment of the overall pharmaceutical market and continues to experience steady growth due to the constant demand for therapeutics targeting prevalent medical conditions.

The biopharmaceutical industry focuses on the development and production of pharmaceutical products derived from biological sources, such as living organisms or their components. Biopharmaceuticals include a wide range of products like monoclonal antibodies, vaccines, recombinant proteins, and gene therapies. These products are often more complex in structure and require advanced manufacturing processes, including biotechnology techniques like cell culture and genetic engineering. The biopharmaceutical sector has witnessed significant growth in recent years due to the increasing prevalence of chronic diseases, personalized medicine approaches, and advancements in biotechnology research. Biopharmaceutical products offer targeted and precise treatments, which have revolutionized disease management and patient care. As a result, this industry has become a key driver of innovation and growth within the pharmaceutical market.

The vaccine industry is dedicated to the development, manufacturing, and distribution of vaccines that prevent infectious diseases and protect public health. Vaccines are biological products designed to stimulate an immune response, providing immunity against specific pathogens. They play a crucial role in preventing the spread of communicable diseases and reducing the burden of infectious outbreaks. The vaccine industry has experienced remarkable growth and technological advancements, particularly in response to global health challenges like the COVID-19 pandemic. Vaccine development requires rigorous testing, clinical trials, and adherence to stringent regulatory standards to ensure safety and efficacy. The ongoing research in immunology and molecular biology continues to drive the innovation of novel vaccines to combat emerging diseases and improve public health outcomes globally. As governments and healthcare organizations prioritize vaccination programs, the vaccine industry remains a vital and indispensable component of the pharmaceutical market.

Breakup by Type:

  • Sterile
  • Non-Sterile
     

Sterile pharmaceutical contract packaging holds the largest share in the market

A detailed breakup and analysis of the market based on the type has also been provided in the report. This includes sterile and non-sterile. According to the report, sterile packaging accounted for the largest market share.

Sterile products are those that are free from any viable microorganisms, making them suitable for direct administration into the body, such as through injections or infusions. They are essential in various medical settings, including hospitals, clinics, and home healthcare. The sterile products are widely used in treating serious and life-threatening medical conditions that require immediate and precise intervention. These products are crucial in emergency situations and surgical procedures, where contamination can have severe consequences. Additionally, the stringent regulatory requirements surrounding the manufacturing and distribution of sterile products contribute to their significance. Health authorities have strict guidelines to ensure the quality and sterility of these products, making the manufacturing process complex and specialized. Moreover, the growing demand for biopharmaceuticals and injectable drugs has further driven the dominance of the sterile segment. As biologics and personalized medicine gain popularity, the need for sterile packaging and administration becomes more pronounced, propelling the growth of this segment within the pharmaceutical market.

Breakup by Packaging:

  • Plastic Bottles
  • Caps and Closures
  • Blister Packs
  • Prefilled Syringes
  • Parenteral Vials and Ampoules
  • Others
     

Plastic bottles dominate the market

The report has provided a detailed breakup and analysis of the market based on the packaging. This includes plastic bottles caps and closures, blister packs, prefilled syringes, parenteral vials and ampoules, and others. According to the report, plastic bottles represented the largest segment.

Plastic bottles offer a combination of versatility and cost-effectiveness that makes them widely preferred across various industries, including pharmaceuticals. Their lightweight nature and durability make them easy to handle during manufacturing, transportation, and storage, reducing overall logistics costs. Additionally, plastic bottles provide excellent barrier properties, protecting pharmaceutical products from external contaminants, moisture, and UV light. This safeguard helps maintain product integrity and extends shelf life, ensuring that medications and healthcare products remain effective and safe for consumption. Furthermore, plastic bottles come in a wide range of shapes and sizes, allowing for customization to meet specific packaging requirements. This flexibility makes them suitable for packaging various forms of pharmaceuticals, from liquid syrups and oral medications to solid tablets and capsules. Moreover, the recyclability of plastic bottles aligns with growing environmental concerns, as manufacturers and consumers increasingly prioritize sustainable packaging solutions. As the demand for eco-friendly packaging continues to rise, plastic bottles' recyclability contributes to their continued dominance as the largest segment in the pharmaceutical packaging market.

Breakup by Region:

  • United States 
  • Europe
  • China 
  • India
  • Others
     

The United States exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include the United States, Europe, China, India, and others. According to the report, the United States was the largest market for pharmaceutical contract packaging.

The U.S. pharmaceutical market is one of the largest and most developed in the world, with a high demand for innovative drugs, medical devices, and healthcare products. The extensive pharmaceutical industry in the U.S. necessitates a robust contract packaging sector to handle the diverse packaging needs of various companies. Additionally, the U.S. pharmaceutical landscape is characterized by a dynamic regulatory environment, with stringent quality and safety standards enforced by agencies such as the Food and Drug Administration (FDA). Contract packaging companies in the U.S. are well-versed in these regulations and adhere to strict compliance protocols, providing assurance to pharmaceutical companies that their products will meet the necessary requirements. Other than this, the U.S. is home to numerous pharmaceutical companies, ranging from multinational corporations to innovative start-ups. Many of these companies prefer to outsource their packaging needs to specialized contract packaging firms to focus on their core competencies and achieve greater operational efficiency. Moreover, the presence of advanced technologies and infrastructure in the U.S. contributes to the country's dominance in the pharmaceutical contract packaging market. These resources enable contract packaging companies to offer a wide array of packaging solutions, including serialization, track-and-trace systems, and customized packaging designs. Furthermore, the U.S. contract packaging industry benefits from a highly skilled and trained workforce with expertise in various aspects of pharmaceutical packaging. This proficiency ensures that contract packaging companies can deliver high-quality and reliable packaging services to their clients.

Competitive Landscape:

Leading contract packaging companies are investing heavily in advanced technologies and automation systems. These investments aim to streamline packaging processes, reduce manual errors, and improve overall operational efficiency. Automation enables faster and more precise packaging, leading to increased production capacities and shorter time-to-market for pharmaceutical products. Additionally, key players in the market are expanding their geographic presence to tap into emerging markets and cater to the growing demand for contract packaging services globally. By establishing facilities in strategic locations, they can provide localized services and offer more cost-effective solutions to pharmaceutical companies seeking to enter new regions. Other than this, environmental sustainability has become a significant concern for consumers and businesses alike. Many key players in the pharmaceutical contract packaging market are incorporating sustainable practices, such as using eco-friendly materials and optimizing packaging designs to reduce waste. These efforts align with the increasing demand for environmentally responsible packaging solutions. Furthermore, to broaden their service offerings and cater to diverse customer needs, key players often engage in collaborations and partnerships. These collaborations may involve joint ventures, technology-sharing agreements, or strategic alliances with pharmaceutical companies and other stakeholders. Such partnerships foster innovation, knowledge exchange, and access to a wider customer base.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided.

Pharmaceutical Contract Packaging Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
  • Industry 
  • Type
  • Packaging
  • Region 
Industries Covered Small Molecule, Biopharmaceutical, Vaccine
Types Covered Sterile, Non-Sterile
Packagings Covered Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, Others
Regions Covered  United States, Europe, China, India, Others
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the pharmaceutical contract packaging market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global pharmaceutical contract packaging market.
  • The study maps the leading, as well as the fastest-growing, regional markets.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the pharmaceutical contract packaging industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Key Questions Answered in This Report

The global pharmaceutical contract packaging market was valued at US$ 21.7 Billion in 2023.

We expect the global pharmaceutical contract packaging market to exhibit a CAGR of 6.8% during 2024-2032.

The rising demand for pharmaceutical contract packaging solutions, as they are relatively flexible and profitable, along with the increasing utilization of smart labels, is primarily driving the global pharmaceutical contract packaging market.

The sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of pharmaceutical contract packaging for assembling and packaging novel medicines and vaccines to mitigate the spread of the coronavirus infection.

Based on the type, the global pharmaceutical contract packaging market has been segregated into sterile and non-sterile. Currently, sterile pharmaceutical contract packaging exhibits a clear dominance in the market.

Based on the packaging, the global pharmaceutical contract packaging market can be bifurcated into plastic bottles, caps and closures, blister packs, prefilled syringes, parenteral vials and ampoules, and others. Among these, plastic bottles currently hold the largest market share.

On a regional level, the market has been classified into United States, Europe, China, India, and others, where United States currently dominates the global market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Pharmaceutical Contract Packaging Market Report by Industry (Small Molecule, Biopharmaceutical, Vaccine), Type (Sterile, Non-sterile), Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More